CGEN Q4 2025 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena

CGENCompugen Ltd.

$202M

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$67M+4477.3% YoY

Gross Profit

$64M94.7% margin

Operating Income

$56M83.2% margin

Net Income

$57M84.4% margin

EPS (Diluted)

$0.60

QoQ Revenue Growth

+3460.7%

Cash Flow

Operating Cash Flow

$32M

Free Cash Flow

$31M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$157M

Total Liabilities

$54M

Stockholders' Equity

$103M

Cash & Equivalents

$91M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$67M	$1M	+4477.3%
Gross Profit	$64M	$796,000	+7914.6%
Operating Income	$56M	-$7M	+848.9%
Net Income	$57M	-$6M	+1029.3%